Acute myeloid leukaemia associated with Muir-Torre variant of hereditary non-polyposis colon cancer (HNPCC): Implications for inherited and acquired mutations in DNA mismatch repair genes

British Journal of Haematology

Volumn 156, Issue 2, 2012, Pages 289-291

  Tailor, Imran K ^a   Cook, Jackie ^a   Reilly, John T ^a   Dalley, Chris D ^a   Ezaydi, Yusof ^a   Kelsey, Philipa J ^b   Snowden, John A ^a,c  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute myeloid leukaemia; DNA mismatch repair genes; Hereditary non polyposis colon cancer; HSC transplantation; MSH2 gene

Indexed keywords

ALEMTUZUMAB; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; IDARUBICIN; MELPHALAN; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; CHROMOSOME TRANSLOCATION 6; CHROMOSOME TRANSLOCATION 9; COLON CARCINOMA; DISEASE ASSOCIATION; FAMILY HISTORY; GENE; GENE MUTATION; GENE REARRANGEMENT; GENETIC VARIABILITY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HETEROZYGOTE; HUMAN; LETTER; LEUKEMIA RELAPSE; LIVER METASTASIS; MALE; MHL1 GENE; MISMATCH REPAIR; MSH2 GENE; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; SALVAGE THERAPY;

ADULT; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA, NEOPLASM; GERM-LINE MUTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MUIR-TORRE SYNDROME; MUTATION;

EID: 84155189085     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08862.x     Document Type: Letter

References (8)

1. Abe, M., Tanaka, Y., Shinohara, M., Kosaka, M. & Matsumoto, T. (2000) Myelodysplastic syndrome/acute myelogenous leukaemia related to adjuvant chemotherapy with oral pyrimidine anti-metabolites. British Journal of haematology, 111, 712-713.
2. Bandipalliam, P. (2005) Syndrome of early onset colon cancers, haematological malignancies and features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Familial Cancer, 4, 323-333.
3. Coldron, J. & Reid, I. (2001) Muir- Torre Syndrome. Journal of Royal College of Surgeons Edinburgh, 46, 178-179.
4. Kayser, S., Döhner, K., Krauter, J., Köhne, C.-H., Horst, H.A., Held, G., von Lilienfeld-Toal, M., Wilhelm, S., Kündgen, A., Götze, K., Rummel, M., Nachbaur, D., Schlegelberger, B., Göhring, G., Späth, D., Morlok, C., Zucknick, M., Ganser, A., Döhner, H., Schlenk, R.F. & for the German-Austrian AMLSG. (2011) The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood, 117, 2137-2145.
5. Lowsky, R., Lipton, J., Fyles, G., Minden, M., Meharchand, J., Tejpar, I., Atkins, H., Sutcliffe, S. & Messner, H. (1994) Secondary malignancies after bone marrow transplantation in adults. Journal of Clinical Oncology, 1, 2187-2192.
6. Mao, G., Yuan, F., Absher, K., Jennings, C.D., Howard, D.S., Jordan, C.T. & Gu, L. (2008) Preferential loss of mismatch repair function in refractory and relapsed acute myeloid leukaemia: potential contribution to AML progression. Cell Research, 18, 281-289.
7. Scott, R.H., Mansour, S., Pritchard-Jones, K., Kumar, D., MacSweeney, F. & Rahman, N. (2007) Medulloblastoma, acute myelocytic leukaemia and colonic carcinomas in a child with biallelic MSH6 mutations. Nature Clinical Practice Oncology, 4, 130-134.
8. Syngal, S. (2000) Hereditary nonpolyposis colorectal cancer: a call for attention. Journal of Clinical Oncology, 18, 2189-2192.